183 related articles for article (PubMed ID: 14673051)
1. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
[TBL] [Abstract][Full Text] [Related]
2. Itraconazole in human medicine and veterinary practice.
Sousa YV; Santiago MG; de Souza BM; Keller KM; Oliveira CSF; Mendoza L; Vilela RVR; Goulart GAC
J Mycol Med; 2024 Jun; 34(2):101473. PubMed ID: 38493607
[TBL] [Abstract][Full Text] [Related]
3. Itraconazole - a potent antifungal drug.
Panda NK
Indian J Otolaryngol Head Neck Surg; 1997 Jul; 49(3):293-4. PubMed ID: 23119315
[TBL] [Abstract][Full Text] [Related]
4. Managing infectious challenges in the age of molecular-targeted therapies for adult hematological malignancies.
Shah M; El Chaer F; Ho DY; El Boghdadly Z
Transpl Infect Dis; 2024 Jun; 26(3):e14283. PubMed ID: 38698640
[TBL] [Abstract][Full Text] [Related]
5. Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Stemler J; Mellinghoff SC; Khodamoradi Y; Sprute R; Classen AY; Zapke SE; Hoenigl M; Krause R; Schmidt-Hieber M; Heinz WJ; Klein M; Koehler P; Liss B; Koldehoff M; Buhl C; Penack O; Maschmeyer G; Schalk E; Lass-Flörl C; Karthaus M; Ruhnke M; Cornely OA; Teschner D
J Antimicrob Chemother; 2023 Aug; 78(8):1813-1826. PubMed ID: 37311136
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis.
Dhoot D; Jain GK; Manjhi M; Kesharwani P; Mahadkar N; Barkate H
Drugs Context; 2023; 12():. PubMed ID: 36660014
[TBL] [Abstract][Full Text] [Related]
7. Pre-emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer.
Uneno Y; Imura H; Makuuchi Y; Tochitani K; Watanabe N
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013604. PubMed ID: 36440894
[TBL] [Abstract][Full Text] [Related]
8. Drug exposure: still relevant after all these years.
Gerber DE; Putnam WC
Oncotarget; 2021 Apr; 12(8):721-722. PubMed ID: 33889295
[No Abstract] [Full Text] [Related]
9. Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung Cancer.
Gerber DE; Putnam WC; Fattah FJ; Kernstine KH; Brekken RA; Pedrosa I; Skelton R; Saltarski JM; Lenkinski RE; Leff RD; Ahn C; Padmanabhan C; Chembukar V; Kasiri S; Kallem RR; Subramaniyan I; Yuan Q; Do QN; Xi Y; Reznik SI; Pelosof L; Faubert B; DeBerardinis RJ; Kim J
Clin Cancer Res; 2020 Nov; 26(22):6017-6027. PubMed ID: 32847935
[TBL] [Abstract][Full Text] [Related]
10. Open-Label Crossover Oral Bioequivalence Pharmacokinetics Comparison for a 3-Day Loading Dose Regimen and 15-Day Steady-State Administration of SUBA-Itraconazole and Conventional Itraconazole Capsules in Healthy Adults.
Thompson GR; Lewis P; Mudge S; Patterson TF; Burnett BP
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32457106
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of antifungal agents in patients with hematopoietic stem cell transplantation: a systematic review and network meta-analysis.
Su HC; Hua YM; Feng IJ; Wu HC
Infect Drug Resist; 2019; 12():1311-1324. PubMed ID: 31190920
[No Abstract] [Full Text] [Related]
12. High incidence of invasive fungal infection during acute myeloid leukemia treatment in a resource-limited country: clinical risk factors and treatment outcomes.
Nganthavee V; Phutthasakda W; Atipas K; Tanpong S; Pungprasert T; Dhirachaikulpanich D; Krithin S; Tanglitanon S; Jutidamronphang W; Owattanapanich W; Chayakulkeeree M; Phikulsod P
Support Care Cancer; 2019 Sep; 27(9):3613-3622. PubMed ID: 31165931
[TBL] [Abstract][Full Text] [Related]
13. Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study.
Wang L; Wang Y; Hu J; Sun Y; Huang H; Chen J; Li J; Ma J; Li J; Liang Y; Wang J; Li Y; Yu K; Hu J; Jin J; Wang C; Wu D; Xiao Y; Huang X
Front Med; 2019 Jun; 13(3):365-377. PubMed ID: 30604166
[TBL] [Abstract][Full Text] [Related]
14. Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis.
Zhang J; Liu Y; Nie X; Yu Y; Gu J; Zhao L
Infect Drug Resist; 2018; 11():1283-1297. PubMed ID: 30197526
[TBL] [Abstract][Full Text] [Related]
15. Prevention of Invasive Aspergillosis in High-Risk Patients: Universal Versus Preemptive, Targeted Treatment.
Baddley JW; Apewokin S
Curr Fungal Infect Rep; 2008 Jun; 2():61-68. PubMed ID: 28959373
[TBL] [Abstract][Full Text] [Related]
16. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.
Patterson TF; Thompson GR; Denning DW; Fishman JA; Hadley S; Herbrecht R; Kontoyiannis DP; Marr KA; Morrison VA; Nguyen MH; Segal BH; Steinbach WJ; Stevens DA; Walsh TJ; Wingard JR; Young JA; Bennett JE
Clin Infect Dis; 2016 Aug; 63(4):e1-e60. PubMed ID: 27365388
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).
Boğa C; Bolaman Z; Çağırgan S; Karadoğan İ; Özcan MA; Özkalemkaş F; Saba R; Sönmez M; Şenol E; Akan H; Akova M
Turk J Haematol; 2015 Jun; 32(2):100-17. PubMed ID: 26316478
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral SUBA-itraconazole and sporanox capsule formulations in healthy subjects in fed and fasted states.
Abuhelwa AY; Foster DJ; Mudge S; Hayes D; Upton RN
Antimicrob Agents Chemother; 2015 Sep; 59(9):5681-96. PubMed ID: 26149987
[TBL] [Abstract][Full Text] [Related]
19. Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
Döring M; Eikemeier M; Cabanillas Stanchi KM; Hartmann U; Ebinger M; Schwarze CP; Schulz A; Handgretinger R; Müller I
Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1189-200. PubMed ID: 25680318
[TBL] [Abstract][Full Text] [Related]
20. Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update.
Villafuerte-Gutierrez P; Villalon L; Losa JE; Henriquez-Camacho C
Adv Hematol; 2014; 2014():986938. PubMed ID: 25525436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
